Belite Bio (BLTE) Receivables - Other (2022 - 2025)

Belite Bio (BLTE) posted quarterly Receivables - Other of $700000.0 for Q4 2025, up 21.74% year-over-year from $575000.0 in Q4 2024, and up 11566.67% quarter-over-quarter from $6000.0 in Q3 2025.

Belite Bio (BLTE) Receivables - Other (2022 - 2025) Analysis & Trends

Belite Bio's Receivables - Other history runs 4 years deep, the most recent figure standing at $700000.0 for Q4 2025.

  • In Q4 2025, Receivables - Other rose 21.74% year-over-year to $700000.0; the TTM figure through Dec 2025 stood at $700000.0 (up 21.74% YoY), while the FY2025 annual figure was $700000.0, up 21.74% from the prior year.
  • Receivables - Other for Q4 2025 stood at $700000.0, up from $6000.0 in the prior quarter.
  • The five-year high for Receivables - Other was $818000.0 in Q4 2023, with the low at $2000.0 in Q4 2022.
  • The 4-year median for Receivables - Other is $315500.0 (2024), against an average of $359500.0.
  • The sharpest annual moves came in 2023 and 2025: Receivables - Other jumped 40800.0% in 2023, then tumbled 89.29% in 2025.
  • Belite Bio's Receivables - Other stood at $2000.0 in 2022, then surged by 40800.0% to $818000.0 in 2023, then dropped by 29.71% to $575000.0 in 2024, then gained by 21.74% to $700000.0 in 2025.
  • Business Quant data shows BLTE's Receivables - Other at $700000.0 in Q4 2025, $6000.0 in Q3 2025, and $575000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Belite Bio 6.40 Bn 6.40 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 700,000.00
Dec 31, 2025 700,000.00
Sep 30, 2025 6,000.00
Sep 30, 2025 6,000.00
Dec 31, 2024 575,000.00
Dec 31, 2024 575,000.00
Sep 30, 2024 56,000.00
Sep 30, 2024 56,000.00
Dec 31, 2023 818,000.00
Dec 31, 2023 818,000.00
Dec 31, 2022 2,000.00
Dec 31, 2022 2,000.00